Alkermes plc (8AK.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Add to watchlist

22.00

-1.00

(-4.35%)

At close: 08:12AM CEST

Loading interactive chart...

Zacks
Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
Alkermes' (ALKS) earnings and revenues miss first-quarter 2024 estimates. However, revenues rise year over year on strong proprietary product sales.
PR Newswire
Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk
Alkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and manufacturing facility in Athlone, Ireland to Novo Nordisk. In connection with the closing of the transaction, Alkermes will receive a one-time cash payment for the facility and certain related assets of approximately $91 million.
Zacks
Alkermes (ALKS) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Alkermes (ALKS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.